Agenus, Inc. (AGEN)
5.93
-0.21
(-3.42%)
USD |
NASDAQ |
Nov 20, 15:43
Agenus 30-Day Average Daily Volume : 735450.1 for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 735450.1 |
| November 18, 2026 | 748765.2 |
| November 17, 2026 | 757946.5 |
| November 16, 2026 | 780211.0 |
| November 13, 2026 | 793145.6 |
| November 12, 2026 | 813827.0 |
| November 11, 2026 | 862258.5 |
| November 10, 2026 | 893485.8 |
| November 09, 2026 | 920480.1 |
| November 06, 2026 | 984651.5 |
| November 05, 2026 | 977946.4 |
| November 04, 2026 | 954680.1 |
| November 03, 2026 | 950686.9 |
| November 02, 2026 | 967190.3 |
| October 30, 2026 | 990662.5 |
| October 29, 2026 | 1.041M |
| October 28, 2026 | 1.046M |
| October 27, 2026 | 1.044M |
| October 26, 2026 | 1.042M |
| October 23, 2026 | 1.044M |
| October 22, 2026 | 1.054M |
| October 21, 2026 | 1.065M |
| October 20, 2026 | 1.087M |
| October 19, 2026 | 1.099M |
| October 16, 2026 | 1.108M |
| Date | Value |
|---|---|
| October 15, 2026 | 1.098M |
| October 14, 2026 | 1.093M |
| October 13, 2026 | 1.083M |
| October 12, 2026 | 1.074M |
| October 09, 2026 | 1.080M |
| October 08, 2026 | 1.082M |
| October 07, 2026 | 1.067M |
| October 06, 2026 | 1.068M |
| October 05, 2026 | 1.043M |
| October 02, 2026 | 1.062M |
| October 01, 2026 | 1.078M |
| September 30, 2026 | 1.090M |
| September 29, 2026 | 1.076M |
| September 28, 2026 | 1.054M |
| September 25, 2026 | 1.003M |
| September 24, 2026 | 1.002M |
| September 23, 2026 | 1.019M |
| September 22, 2026 | 1.045M |
| September 21, 2026 | 1.076M |
| September 18, 2026 | 1.072M |
| September 17, 2026 | 1.084M |
| September 16, 2026 | 1.107M |
| September 15, 2026 | 1.152M |
| September 14, 2026 | 1.181M |
| September 11, 2026 | 1.208M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Halozyme Therapeutics, Inc. | 2.350M |
| AVITA Medical, Inc. | 538628.3 |
| Iovance Biotherapeutics, Inc. | 13.77M |
| Xencor, Inc. | 1.614M |
| Amgen, Inc. | 2.663M |